Liposomal Doxorubicin

Liposomal Doxorubicin, also known as Pegylated liposomal doxorubicin (Caelyx®), is a chemotherapy medication used in the treatment of various cancers, including HIV-related Kaposi’s sarcoma.

Administration

• Given intravenously (IV, meaning through the veins) every 21 days, which defines one cycle.
• Different delivery methods, including cannulas, central lines, PICC lines, or implantable ports, are tailored to individual patient needs.
• A chemotherapy nurse, specialized pharmacist, or oncologist will oversee the administration, often in combination with other cancer drugs.
• Before treatment , a blood sample is taken to ensure safe blood cell levels for chemotherapy.
• You may receive oral or IV drugs prior and after the infusion to prevent nausea.
• Imaging is usually repeated every 2-3 cycles to determine the response.
• The number of cycles of treatment will depend on your tolerance to treatment and your response.

Potential Side Effects & Management

While treatment is being given:
• Allergic Reactions: Rapid onset of symptoms like flushing, itching, or swelling requires immediate attention due to sarcoma patients’ specific vulnerability. 
• Extravasation: Drug leakage outside the vein is critical for sarcoma patients. It can impact surrounding tissues, warranting urgent intervention.

Common Side Effects:
• Infection Risk: Given sarcoma treatments’ intensity, reduced white blood cell counts heighten infection risks, necessitating vigilance and timely medical intervention. If you have a fever over 38.3°C, you should advise your medical team or go to the emergency department.
• Bruising and Bleeding: Reduced platelets due to treatment can lead to easy bruising, nosebleeds, or blood in urine/stool. Platelet transfusion might be necessary.
• Anemia: Reduced red blood cells due to treatment can cause anemia. If severe, blood transfusion might be necessary.
• Nausea and Hair Loss: Managing these side effects can significantly impact quality of life during treatment.
• Sore Mouth & Throat: Treatment may cause sore mouth and throat which can potentially lead to mouth ulcers and increased risk of infection. Maintain oral hygiene; contact your healthcare team for mouthwash or medicines if needed.
• Skin Changes: Rash, sensitivity, discoloration; moisturizing and protective measures are recommended.
• Sore and Red Palms, Soles: Palmar-plantar syndrome causes redness and peeling. Keep hands and feet cool, moisturize, and avoid tight-fitting items.
• Numbness and tingling in hands and feet: This treatment can cause numbness, tingling, or pain in the hands or feet; inform your doctor for possible dose adjustments.
• Loss of Appetite: Treatment can impact appetite temporarily. Dietary changes may be suggested.
• Diarrhea: Increased bowel activity; more common if you have a stoma.
• Constipation: inability to pass stools as often as usual. Management includes drinking a lot of fluids, increasing fiber consumption, light exercise, and in severe cases, laxatives may be prescribed.
• Headache, Muscle or Joint Pain: Post-treatment pain in head, muscles or joints may arise; notify your doctor for pain relief, especially if persistent.

Less Common Side Effects:
• Effects on the Lungs: Notify your doctor of any respiratory symptoms like coughing or breathlessness.
• Fluid build-up: Weight gain or swelling; improves after treatment.
• Effects on the Heart: Regular heart function tests are conducted. Report chest pain, breathlessness, or dizziness to your doctor.
• Liver Impact: Potential mild effects on liver function; regular blood tests will monitor liver performance.

Precautionary Measures for Sarcoma Patients

• Blood clot risk: Report symptoms like swelling, breathlessness, or sharp chest pain immediately.
• Communication: Always prioritize informing your healthcare team about ongoing sarcoma treatments, ensuring coordinated care and potential adjustments.
• Vaccinations: Sarcoma patients should be aware of vaccination recommendations, especially considering treatment impacts on immune responses.
• Sex and Contraception: Gemcitabine may impact fertility; discuss and plan contraception strategies with your oncologists.
• Breastfeeding: Avoid while having treatment.

Understanding the details of this treatment, including its administration, potential side effects, and precautionary measures, empowers patients to actively participate in their care and optimize treatment outcomes. Always communicate openly with your healthcare team for personalized guidance and support.

Scroll to Top